1. Home
  2. >>Scrip
  3. >>Business
  4. >>Deals
  5. >>Deal Watch

Deal Watch

Asia Deal Watch: Daiichi Taps Into Wayfinder’s RNA-Encoding Platform

 
• By Jung Won Shin, Lisa Takagi, Joseph Haas, Anju Ghangurde, and Vibha Ravi

Plus deals involving Elix/PRISM, Rege/Syros, Kaken/KalVista, Dr. Reddy’s/Aurigene/Edity, Nissan Chemical/Sanwa, Lupin/Renascience, Shionogi/Link Medicine, Abbisko/Merck & Co., Ono/Reborna and Apollomics/LaunXp.

Deal Watch: Oak Hill Picks Up Where Roche Left Off In Angelman Syndrome

 
• By Joseph Haas

Plus deals involving Spruce/BioMarin, Boehringer Ingelheim/Cue, Onconetix/Ocuvex, Allakos/Concentra, Sanofi/Nurix, Pfizer/Flagship Pioneering, Alcon/Aurion and more.

Asia Deal Watch: Dr. Reddy’s Gets Regional Rights To Pair Of Bio-Thera Biosimilars

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Plus deals involving GV20/Mitsubishi Tanabe, Kaken/Alumis, AstraZeneca/Alteogen and deal terminations involving Clover/Gavi Alliance and Rhythm/RareStone.

Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq

 
• By Joseph Haas

Plus deals involving Relmada/Trigone, Alvotech/Xbrane, OPKO Health/Entera, iOncologi/TargImmune and more.

Asia Deal Watch: Daiichi Sankyo Teams With Nosis On Extrahepatic RNA Therapies

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Plus deals involving Hyundai/Pharma/Avelos, Yuhan/Boehringer Ingelheim, SciClone/Eisai, Viatris/Nxera/Idorsia, Nxera/Holling and Takeda/BridGene.

Deal Watch: Amgen, CytomX Pull Back On Part Of T-Cell Engager Collaboration

 
• By Joseph Haas

Vertex, Sanofi, Hansoh and BMS/Myokardia have also recently exited deals. Callio launched with ADC technology from Hummingbird, plus more deals and tech transfer.

Asia Deal Watch: AstraZeneca Buys FibroGen’s Chinese Subsidiary

 
• By Joseph Haas, Vibha Ravi, Lisa Takagi, Dexter Jie Yan, and Jung Won Shin

Plus deals involving Pfizer/Mylan, Radiance/CSPC, Polymed/Photys, Kyorin/Cyrano, Zydus/Synthon, Ellipses/Genome & Co., OliX/Lilly, AdvanCell/Lilly and more.

Deal Watch: FTC Keeps Current Merger Guidelines In Place, For Now

 
• By Joseph Haas

Plus deals involving Incyte/Genesis, Merck & Co./Epitopea, Merck Serono/Asceneuron, Tivic Health/Statera and more.

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Vibha Ravi

Plus deals involving Vanda/AnaptysBio, OS Therapies/Ayala, Leveragen/Moonlight Bio, Lantheus/Evergreen, Exicure/GPCR, Arrivent/Lepu, InnoCare/KeyMed/Prolium and more.

Asia Deal Watch: Regenxbio Licenses Two MPS Gene Therapies To Nippon Shinyaku

 
• By Joseph Haas, Lisa Takagi, and Dexter Jie Yan

Plus deals involving Simcere/AbbVie, Daiichi Sankyo/Glycotope, Telix/ImaginAb, Harbour/Kelun/Windward, Insilico/Menarini, Samsung Bioepis/Teva, HealZen/J&J, Zai Lab/Vertex, Zai Lab/MediLink and Primrose/Serum Institute of India.

Deal Watch: Bausch Companies Set Hectic Pace At J.P. Morgan With Five Deals

 
• By Joseph Haas

Plus deals involving Lantheus/Life Molecular Imaging, Teva/Klinge/Formycon, X4/Norgine, Biohaven/Merus, Lilly/Mediar and more.

Deal Watch: Lilly Looks To Alchemab’s ‘Resilient’ Antibodies To Take On ALS

 
• By Joseph Haas and Jung Won Shin

Plus deals involving Synaffix/Mitsubishi Tanabe/Boehringer Ingelheim, Newron/Myung In, Vividion/Tavros, Novo Nordisk/Variant, Vertex/Orna, Sanofi/Alloy and more.

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular

 
• By Joseph Haas and Dexter Jie Yan

Plus deals involving Pfizer/Atavistik, Immedica/Marinus, J&J/Kaken, Ikena/Inmagene, Corxel/Vincentage, Rapt/Jemincare, Sanofi/Corxel, Bristol Myers Squibb/BioArctic, NGM/kdT Ventures and more.

Asia Deal Watch: Kaken Obtains Aadi Subsidiary And Cancer Drug Fyarro

 
• By Joseph Haas, Lisa Takagi, Ian Haydock, and Vibha Ravi

Plus deals involving Hangzhou DAC/Aadi, Astellas/Sangamo, Kyorin/Bayer, Eisai/Newron, Lupin/Boehringer Ingelheim, Asahi Kasei/Chiome and more.

Deal Watch: Merck Decides Better Late Than Never In GLP-1 Deal With Hansoh

 
• By Joseph Haas

Plus deals involving Novartis/BioAge, Novo Nordisk/Photys, Tvardi/Cara, Gilead/Terray, Candid/Ab Studio/EpimAb/Nona, AbbVie/Nimble and more.

Deal Watch: GSK Extends Its Shingrix Alliance In China With Zhifei

 
• By Joseph Haas

Plus deals involving Mitsubishi Tanabe/Dewpoint, Lilly/Rondo, Ono/Congruence, Bristol Myers Squibb/AI Proteins and more.

Deal Watch: Sarepta Targets RNAi In Broad Collaboration With Arrowhead

 
• By Joseph Haas

Plus deals involving Novartis with Vyriad, Ratio and Schrödinger; Pharmanovia/Lindis, Pulmatrix/Cullgen, Entero/Journey, Roche/Flare and AlloVir/Kalaris.

Asia Deal Watch: Otsuka Lands Second Alliance With Ionis, Focused On ALS Subpopulation

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Plus deals involving Zai Lab/Pfizer, Laekna/Lilly, Takeda/Alloy, Lunit/AstraZeneca, VelaVigo/Avenzo, Biosion/Aclaris, HCW/WY Biotech, Celltrion/iQone and Kaken/Numab.

Deal Watch: Renexxion To Go Public While Avid Biosciences Goes Private

 
• By Joseph Haas

Plus deals involving Synaffix/BigHat, AbbVie/EvolveImmune, Servier/Aitia, Dr. Falk/Kynos, Bayer/Dewpoint and more.

Asia Deal Watch: Cureverse Licenses Option For Neurology Candidate To Angelini

 
• By Joseph Haas, Lisa Takagi, Dexter Jie Yan, and Jung Won Shin

Plus deal news involving LianBio/NImmune, REGiMMUNE/Kiji, Chengdu Baiyu/Novartis, Orasis/Optus, Takeda/Wave Life Sciences, Ono/LigaChem, Alchem/Sonnet, Astellas/AviadoBio, Innovent/Ask Pharm and Dr Reddy’s/Gilead.